LFR
SRPT icon

Lehman Financial Resources’s Sarepta Therapeutics SRPT Stock Holding History

Lehman Financial Resources’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$1.04M Hold
6,442
– – 0.49% 32
2018
Q2 		$851K Hold
6,442
– – 0.43% 37
2018
Q1 		$477K Sell
6,442
-1,311
-17% -$87.4K 0.24% 49
2017
Q4 		$431K Buy
7,753
+1,361
+21% +$72.1K 0.22% 52
2017
Q3 		$289K Sell
6,392
-469
-7% -$18.7K 0.15% 55
2017
Q2 		$228K Hold
6,861
– – 0.13% 56
2017
Q1 		$203K Buy
+6,861
New +$212K 0.11% 60
2016
Q4 		– Sell
-3,861
Closed -$237K – 63
2016
Q3 		$237K Buy
+3,861
New +$117K 0.14% 50
2016
Q2 		– Sell
-41,311
Closed -$806K – 63
2016
Q1 		$806K Hold
41,311
– – 0.43% 36
2015
Q4 		$1.59M Hold
41,311
– – 0.86% 28
2015
Q3 		$1.33M Sell
41,311
-9,600
-19% -$326K 0.68% 30
2015
Q2 		$1.55M Buy
50,911
+24,300
+91% +$497K 0.75% 28
2015
Q1 		$353K Buy
26,611
+1,700
+7% +$22.7K 0.16% 49
2014
Q4 		$360K Buy
24,911
+7,000
+39% +$119K 0.18% 49
2014
Q3 		$378K Sell
17,911
-400
-2% -$9.03K 0.2% 45
2014
Q2 		$545K Hold
18,311
– – 0.26% 44
2014
Q1 		$440K Buy
18,311
+1,000
+6% +$25.5K 0.23% 44
2013
Q4 		$353K Hold
17,311
– – 0.22% 45
2013
Q3 		$818K Sell
17,311
-3,521
-17% -$136K 0.52% 35
2013
Q2 		$792K Buy
+20,832
New +$745K 0.54% 32

Other funds holding SRPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Lehman Financial Resources's SRPT Position: Q3 2018 in Review

Lehman Financial Resources held its Sarepta Therapeutics (SRPT) position steady in Q3 2018 at 6,442 shares worth $1.04M. The position accounts for 0.49% of the portfolio, ranked #32.

Lehman Financial Resources first reported a position in SRPT in Q2 2013 and has held it in 20 quarters since. The position peaked at $1.59M in Q4 2015. 344 funds tracked by Wall St. Rank hold SRPT as of Q3 2018.

  • Lehman Financial Resources held 6,442 shares of Sarepta Therapeutics worth $1.04M as of Q3 2018.
  • Lehman Financial Resources left its Sarepta Therapeutics share count unchanged in Q3 2018.
  • Sarepta Therapeutics made up 0.49% of Lehman Financial Resources's portfolio in Q3 2018, its #32 holding.
  • Lehman Financial Resources first reported a position in Sarepta Therapeutics in Q2 2013 and has held it in 20 quarters since.
  • Lehman Financial Resources's Sarepta Therapeutics position peaked at $1.59M in Q4 2015.
  • 344 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2018.

Based on Lehman Financial Resources's 13F filing for Q3 2018, filed 14 Nov 2018.